Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

AM-0715

Known as: AM 0715, AM 715, AM0715 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
1. Ito, A., Hirai, K., Inoue, M., Koga, H., Suzue, S., Irikura, T., Mitsuhashi, S.: In vitro antibacterial activity of AM-715, a… Expand
  • table 1
  • table 1
  • table 2
Is this relevant?
1990
1990
Norfloxacin (NFLX, AM-715), a new quinolone antibiotic agent, was evaluated clinically and bacteriologically for its efficacy and… Expand
Is this relevant?
1983
1983
The mechanisms of the renal excretion of AM-715, a synthetic antimicrobial agent, were studied in rabbits, dogs, and humans. In… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1983
1983
A comparison was made of the in vitro activities of norfloxacin and of nine other orally administered antibacterial agents… Expand
  • table 1
Is this relevant?
1983
1983
Norfloxacin is a new orally absorbed quinoline derivative structurally related to nalidixic acid but showing an expanded… Expand
Is this relevant?
1983
1983
Norfloxacin is a new organic acid antimicrobic with an expanded spectrum that includes Staphylococcus spp, most Pseudomonas spp… Expand
Is this relevant?
1981
1981
Dose for dose, AM-715 was at least five times as active as pipemidic acid and nalidixic acid against systemic and urinary bladder… Expand
Is this relevant?
1981
1981
The in vitro activity of a new ora antimicrobial agent, Mk-0366 (AM-715), was compared with those of rosoxacin, ampicillin… Expand
Is this relevant?
Highly Cited
1980
Highly Cited
1980
AM-715 [1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid] is a new nalidixic acid analog. AM-715… Expand
Is this relevant?